Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy

PURPOSE: To evaluate the safety and efficacy of stereotactic body radiation therapy for primary lesion of renal cell carcinoma with long-term and regular follow-up of tumor size and renal function. METHODS: This prospective study included 13 patients treated with stereotactic body radiation therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Funayama, Satoshi, Onishi, Hiroshi, Kuriyama, Kengo, Komiyama, Takafumi, Marino, Kan, Araya, Masayuki, Saito, Ryo, Aoki, Shinichi, Maehata, Yoshiyasu, Nonaka, Hotaka, Tominaga, Licht, Muramatsu, Juria, Nakagomi, Hiroshi, Kamiyama, Manabu, Takeda, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373992/
https://www.ncbi.nlm.nih.gov/pubmed/30803362
http://dx.doi.org/10.1177/1533033818822329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373992/
https://www.ncbi.nlm.nih.gov/pubmed/30803362
http://dx.doi.org/10.1177/1533033818822329

Ejemplares similares